Scleroderma risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:
*Common risk factors in the development of scleroderma include occupational exposure to certain chemicals, certain [[genetic]] variations and [[infectious]] agents.
*Common risk factors in the development of scleroderma include occupational exposure to certain chemicals, certain [[genetic]] variations and [[infectious]] agents.
===Common Risk Factors===
===Common Risk Factors===
*Common risk factors in the development of scleroderma may be occupational, environmental, [[genetic]], and [[infectious]]:
Common risk factors in the development of scleroderma may be occupational, environmental, [[genetic]], and [[infectious]]:
**Occupational and environmental exposure to:<ref name="pmid12151611">{{cite journal |vauthors=Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, Stadler M, Diot P, Lemarie E, Lasfargues G |title=Systemic sclerosis and occupational risk factors: a case-control study |journal=Occup Environ Med |volume=59 |issue=8 |pages=545–9 |date=August 2002 |pmid=12151611 |pmc=1740346 |doi= |url=}}</ref><ref name="pmid22269658">{{cite journal |vauthors=Barnes J, Mayes MD |title=Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers |journal=Curr Opin Rheumatol |volume=24 |issue=2 |pages=165–70 |date=March 2012 |pmid=22269658 |doi=10.1097/BOR.0b013e32834ff2e8 |url=}}</ref><ref name="pmid23287382">{{cite journal |vauthors=Dospinescu P, Jones GT, Basu N |title=Environmental risk factors in systemic sclerosis |journal=Curr Opin Rheumatol |volume=25 |issue=2 |pages=179–83 |date=March 2013 |pmid=23287382 |doi=10.1097/BOR.0b013e32835cfc2d |url=}}</ref><ref name="pmid24129037">{{cite journal |vauthors=Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H |title=Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature |journal=Autoimmun Rev |volume=13 |issue=2 |pages=151–6 |date=February 2014 |pmid=24129037 |doi=10.1016/j.autrev.2013.10.002 |url=}}</ref>
*Occupational and environmental exposure to:<ref name="pmid12151611">{{cite journal |vauthors=Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, Stadler M, Diot P, Lemarie E, Lasfargues G |title=Systemic sclerosis and occupational risk factors: a case-control study |journal=Occup Environ Med |volume=59 |issue=8 |pages=545–9 |date=August 2002 |pmid=12151611 |pmc=1740346 |doi= |url=}}</ref><ref name="pmid22269658">{{cite journal |vauthors=Barnes J, Mayes MD |title=Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers |journal=Curr Opin Rheumatol |volume=24 |issue=2 |pages=165–70 |date=March 2012 |pmid=22269658 |doi=10.1097/BOR.0b013e32834ff2e8 |url=}}</ref><ref name="pmid23287382">{{cite journal |vauthors=Dospinescu P, Jones GT, Basu N |title=Environmental risk factors in systemic sclerosis |journal=Curr Opin Rheumatol |volume=25 |issue=2 |pages=179–83 |date=March 2013 |pmid=23287382 |doi=10.1097/BOR.0b013e32835cfc2d |url=}}</ref><ref name="pmid24129037">{{cite journal |vauthors=Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H |title=Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature |journal=Autoimmun Rev |volume=13 |issue=2 |pages=151–6 |date=February 2014 |pmid=24129037 |doi=10.1016/j.autrev.2013.10.002 |url=}}</ref>
***Crystaline [[silica]]
**Crystaline [[silica]]
***Trichlorethylene
**Trichlorethylene
***Chlorinated [[solvents]]
**Chlorinated [[solvents]]
***[[Toluene]]
**[[Toluene]]
***[[Aromatic]] [[solvents]]
**[[Aromatic]] [[solvents]]
***[[Ketones]]
**[[Ketones]]
***White spirit
**White spirit
***[[Epoxy resins]]
**[[Epoxy resins]]
***Welding [[fumes]]
**Welding [[fumes]]
**[[Genetic]] variations in:<ref name="urlSystemic scleroderma - Genetics Home Reference,US national library of medicine">{{cite web |url=https://ghr.nlm.nih.gov/condition/systemic-scleroderma#sourcesforpage |title=Systemic scleroderma - Genetics Home Reference |format= |work= |accessdate=}}</ref>
*[[Genetic]] variations in:<ref name="urlSystemic scleroderma - Genetics Home Reference,US national library of medicine">{{cite web |url=https://ghr.nlm.nih.gov/condition/systemic-scleroderma#sourcesforpage |title=Systemic scleroderma - Genetics Home Reference |format= |work= |accessdate=}}</ref>
***[[Human leukocyte antigens|Human leukocyte antigen (HLA) genes]]
**[[Human leukocyte antigens|Human leukocyte antigen (HLA) genes]]
***[[IRF5]] [[gene]]
**[[IRF5]] [[gene]]
***[[STAT4]] [[gene]]
**[[STAT4]] [[gene]]
**[[Infectious]] agents:<ref name="pmid21158008">{{cite journal |vauthors=Radić M, Martinović Kaliterna D, Radić J |title=Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis |journal=Neth J Med |volume=68 |issue=11 |pages=348–53 |date=November 2010 |pmid=21158008 |doi= |url=}}</ref><ref name="pmid19758208">{{cite journal |vauthors=Arnson Y, Amital H, Guiducci S, Matucci-Cerinic M, Valentini G, Barzilai O, Maya R, Shoenfeld Y |title=The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies |journal=Ann. N. Y. Acad. Sci. |volume=1173 |issue= |pages=627–32 |date=September 2009 |pmid=19758208 |doi=10.1111/j.1749-6632.2009.04808.x |url=}}</ref>
*[[Infectious]] agents:<ref name="pmid21158008">{{cite journal |vauthors=Radić M, Martinović Kaliterna D, Radić J |title=Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis |journal=Neth J Med |volume=68 |issue=11 |pages=348–53 |date=November 2010 |pmid=21158008 |doi= |url=}}</ref><ref name="pmid19758208">{{cite journal |vauthors=Arnson Y, Amital H, Guiducci S, Matucci-Cerinic M, Valentini G, Barzilai O, Maya R, Shoenfeld Y |title=The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies |journal=Ann. N. Y. Acad. Sci. |volume=1173 |issue= |pages=627–32 |date=September 2009 |pmid=19758208 |doi=10.1111/j.1749-6632.2009.04808.x |url=}}</ref>
***[[Cytomegalovirus]] ([[CMV]])
**[[Cytomegalovirus]] ([[CMV]])
***[[Hepatitis B virus]] ([[HBV]])
**[[Hepatitis B virus]] ([[HBV]])
***[[Toxoplasma gondii]] infection ([[toxoplasmosis]])
**[[Toxoplasma gondii]] infection ([[toxoplasmosis]])


===Less Common Risk Factors===
===Less Common Risk Factors===

Revision as of 17:16, 28 March 2018

Scleroderma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Scleroderma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Scleroderma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Scleroderma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Scleroderma risk factors

CDC on Scleroderma risk factors

Scleroderma risk factors in the news

Blogs on Scleroderma risk factors

Directions to Hospitals Treating Scleroderma

Risk calculators and risk factors for Scleroderma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Overview

Common risk factors in the development of scleroderma include occupational and environmental exposure to certain chemicals, certain genetic variations and infectious agents. Most commonly implicated occupational and environmental risk factors are exposure is to silica, chlorinated and aromatic solvents as well as welding fumes.

Risk Factors

  • Common risk factors in the development of scleroderma include occupational exposure to certain chemicals, certain genetic variations and infectious agents.

Common Risk Factors

Common risk factors in the development of scleroderma may be occupational, environmental, genetic, and infectious:

Less Common Risk Factors

Less common risk factors in the development of scleroderma include:

References

  1. Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, Stadler M, Diot P, Lemarie E, Lasfargues G (August 2002). "Systemic sclerosis and occupational risk factors: a case-control study". Occup Environ Med. 59 (8): 545–9. PMC 1740346. PMID 12151611.
  2. Barnes J, Mayes MD (March 2012). "Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers". Curr Opin Rheumatol. 24 (2): 165–70. doi:10.1097/BOR.0b013e32834ff2e8. PMID 22269658.
  3. 3.0 3.1 Dospinescu P, Jones GT, Basu N (March 2013). "Environmental risk factors in systemic sclerosis". Curr Opin Rheumatol. 25 (2): 179–83. doi:10.1097/BOR.0b013e32835cfc2d. PMID 23287382.
  4. Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (February 2014). "Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature". Autoimmun Rev. 13 (2): 151–6. doi:10.1016/j.autrev.2013.10.002. PMID 24129037.
  5. "Systemic scleroderma - Genetics Home Reference".
  6. Radić M, Martinović Kaliterna D, Radić J (November 2010). "Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis". Neth J Med. 68 (11): 348–53. PMID 21158008.
  7. Arnson Y, Amital H, Guiducci S, Matucci-Cerinic M, Valentini G, Barzilai O, Maya R, Shoenfeld Y (September 2009). "The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies". Ann. N. Y. Acad. Sci. 1173: 627–32. doi:10.1111/j.1749-6632.2009.04808.x. PMID 19758208.
  8. De Martinis M, Ciccarelli F, Sirufo MM, Ginaldi L (2016). "An overview of environmental risk factors in systemic sclerosis". Expert Rev Clin Immunol. 12 (4): 465–78. doi:10.1586/1744666X.2016.1125782. PMID 26610037.

Template:WH Template:WS